Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,570 Prostate Cancer
clinical trials

Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Medical Center-Rice Lake
1593
mi
from 91732
Rice Lake, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Rowan Regional Medical Center
2117
mi
from 91732
Salisbury, NC
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Washington
941
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth United General Medical Center
1020
mi
from 91732
Sedro-Woolley, WA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Ascension Providence Hospitals - Southfield
1958
mi
from 91732
Southfield, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Southwest Illinois Health Services LLP
1584
mi
from 91732
Swansea, IL
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
National Jewish Health-Northern Hematology Oncology
822
mi
from 91732
Thornton, CO
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health Virginia Clinic
1612
mi
from 91732
Virginia, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Breast Specialists-Warren
1969
mi
from 91732
Warren, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Advanced Breast Care Center PLLC
1970
mi
from 91732
Warren, MI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Wheaton Franciscan Healthcare-Saint Joseph/Wauwatosa Campus
1722
mi
from 91732
Wauwatosa, WI
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
William E Kahlert Regional Cancer Center/Sinai Hospital
2280
mi
from 91732
Westminster, MD
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Woodland Hills
34
mi
from 91732
Woodland Hills, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Cancer Center Worthington
1368
mi
from 91732
Worthington, MN
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Wellspan Health - York Cancer Center
2292
mi
from 91732
York, PA
Click here to add this to my saved trials
Cancer Clinical Trial
Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
GSK Investigational Site
5431
mi
from 91732
London,
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
2438
mi
from 91732
Abany, NY
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
5
mi
from 91732
Duarte, CA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
2369
mi
from 91732
Easton, PA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
2119
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
An Expanded Access Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy
Status: Enrolling, Phase IV
Updated: 8/16/2016
Clinical Research Facility
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
2313
mi
from 91732
Lancaster, PA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Status: Enrolling, Phase IV
Updated: 4/1/2016
Clinical Research Facility
1975
mi
from 91732
St. Clair Shores, MI
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
UZ Antwerpen
5590
mi
from 91732
Edegem,
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Oncology Associates - Hampton
2341
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
UC (Urothelial Cancer) Clinical Trial
A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)
Status: Enrolling, Phase II
Updated: 12/31/1969
UCSF Helen Diller Family Comprehensive Care Center
353
mi
from 91732
San Francisco, CA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology & Hematology Specialists
1650
mi
from 91732
Metairie, LA
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Penn State Cancer Intsitute
2295
mi
from 91732
Hershey, PA
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1932
mi
from 91732
Ann Arbor, MI
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1586
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memoral Sloan Kettering Westchester
2447
mi
from 91732
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering @ Rockville
2452
mi
from 91732
Rockville Centre, NY
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2433
mi
from 91732
Poughkeepsie, NY
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1208
mi
from 91732
Round Rock, TX
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib Versus Physician's Choice of Therapy in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
43
mi
from 91732
San Bernardino, CA
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2180
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2433
mi
from 91732
Poughkeepsie, NY
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
105
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
964
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
1315
mi
from 91732
Tyler, TX
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/30/2016
Manatee Medical Research
2140
mi
from 91732
Brandenton, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/30/2016
Lincoln Urology, PC
1255
mi
from 91732
Lincoln, NE
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
AASUR in High Risk Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Bergen
2428
mi
from 91732
Montvale, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
2234
mi
from 91732
Myrtle Beach, SC
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)
Status: Enrolling, Phase II
Updated: 12/31/1969
Merck Sharp & Dohme
7515
mi
from 91732
North Ryde,
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Neoadjuvant Nivolumab With and Without Urelumab in Patients With Cisplatin-Ineligible Muscle-Invasive Urothelial Carcinoma of the Bladder
Status: Enrolling, Phase II
Updated: 12/31/1969
UCLA Institute of Urologic Oncology
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Advanced Radiation Centers of New York (Integrated Medical Professionals)
2440
mi
from 91732
Bronx, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Southwest Urology, Clinical Research Solutions
2026
mi
from 91732
Middleburg Heights, OH
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwest Medical Specialists
1712
mi
from 91732
Arlington Heights, IL
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Hca Midwest Division
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Monmouth
2428
mi
from 91732
Middletown, NJ
Click here to add this to my saved trials
Cancer of Prostate Clinical Trial
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
Status: Enrolling, Phase
Updated: 12/31/1969
Walter Reed National Military Medical CPDR
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
2410
mi
from 91732
New Brunswick, NJ
Click here to add this to my saved trials
Urothelial Cancer Clinical Trial
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Taussing Cancer Center
2035
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Cancer-related Problem/Condition Clinical Trial
Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Executive Park 12
1921
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
2180
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - La Jolla
94
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - St. Louis
1568
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Tampa
2135
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Status: Enrolling, Phase
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge
2402
mi
from 91732
Basking Ridge, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Commack
2470
mi
from 91732
Commack, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Maryland Oncology Hematology P.A.
2284
mi
from 91732
Silver Spring, MD
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Enfortumab Vedotin Plus Pembrolizumab and/or Chemotherapy for Patients With Urothelial Bladder Cancer (EV-103)
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Colorado Hospital / University of Colorado
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer
Status: Enrolling
Updated: 12/31/1969
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Cancer Care Specialist, PC
2270
mi
from 91732
Fairfax, VA
Click here to add this to my saved trials
Oncology Clinical Trial
PSMA PET Imaging of Recurrent Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre
2452
mi
from 91732
Rockville Centre, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
MiddleBurg Heights
2025
mi
from 91732
Middleburg Heights, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Pompano Beach
2313
mi
from 91732
Pompano Beach, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigator Site - Tucson
429
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Virginia Beach
2352
mi
from 91732
Virginia Beach, VA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Carolinas Healthcare System - Pineville
2101
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate
Status: Enrolling
Updated: 8/30/2017
Clinical Research Facility
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
2445
mi
from 91732
Harrison, NY
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Tom Baker Cancer Centre
1189
mi
from 91732
Calgary,
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
McLaren Cancer Institute-Clarkston
1952
mi
from 91732
Clarkston, MI
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Lankenau Medical Center
2370
mi
from 91732
Wynnewood, PA
Click here to add this to my saved trials
1 … 57 58 59 60 61 62 63 64 65 66